Sienna Resources Inc
XTSX:SIE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sienna Resources Inc
XTSX:SIE
|
CA |
|
D
|
Dhg Pharmaceutical Joint-Stock Co
VN:DHG
|
VN |
|
Raiznext Corp
TSE:6379
|
JP |
|
A
|
Alliance Pharma PLC
LSE:APH
|
UK |
|
T
|
Toshin Group Co Ltd
TSE:2761
|
JP |
|
C
|
Centurion Accommodation REIT
SGX:8C8U
|
SG |
|
K
|
KNH Enterprise Co Ltd
TWSE:9919
|
TW |
|
B
|
Bionoid Pharma Inc
OTC:BINP
|
US |
|
I
|
iSoftStone Information Technology Group Co Ltd
SZSE:301236
|
CN |
Balance Sheet
Balance Sheet Decomposition
Sienna Resources Inc
Sienna Resources Inc
Balance Sheet
Sienna Resources Inc
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
1
|
0
|
1
|
1
|
0
|
0
|
0
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
1
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
0
|
1
|
0
|
1
|
1
|
0
|
1
|
0
|
|
| PP&E Net |
0
|
0
|
1
|
1
|
1
|
0
|
1
|
1
|
2
|
2
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
1
N/A
|
1
+15%
|
2
+75%
|
2
+36%
|
2
+4%
|
2
-23%
|
2
+21%
|
1
-42%
|
3
+191%
|
2
-35%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
2
|
2
|
2
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
2
|
2
|
2
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
2
N/A
|
2
+5%
|
2
+22%
|
1
-51%
|
1
-5%
|
0
-55%
|
0
-74%
|
0
+127%
|
0
-42%
|
0
+13%
|
|
| Equity | |||||||||||
| Common Stock |
16
|
17
|
18
|
20
|
20
|
23
|
24
|
24
|
27
|
27
|
|
| Retained Earnings |
17
|
18
|
18
|
19
|
23
|
25
|
22
|
23
|
24
|
25
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
4
|
4
|
4
|
4
|
5
|
0
|
|
| Total Equity |
1
N/A
|
1
+6%
|
0
+45%
|
1
N/A
|
1
+12%
|
1
0%
|
2
+51%
|
1
-51%
|
3
+251%
|
2
-37%
|
|
| Total Liabilities & Equity |
1
N/A
|
1
+15%
|
2
+75%
|
2
+36%
|
2
+4%
|
2
-23%
|
2
+21%
|
1
-42%
|
3
+191%
|
2
-35%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
28
|
36
|
40
|
53
|
63
|
110
|
124
|
126
|
195
|
203
|
|